Baricitinib

Red

Brand Name(s):Olumiant

Indication:Rheumatoid Arthritis – moderate to severe

Rationale:1,2,3

Considered:Feb-17

Review Date:Oct-25

Comments:
MHRA Drug Safety Update warns that cases of diverticulitis (DV) and GI perforation have been reported in patients taking baricitinib; most, but not all, cases occurred in patients on concomitant medicines linked to increased risk of DV, therefore baricitinib should be used with caution in these particular groups. https://nice.us8.list-manage.com/track/click?u=7864f766b10b8edd18f19aa56&id=48dece3050&e=4b217053bd